G6PD Assay Kits

Assay Principle

Glucose-6-phosphate dehydrogenase (G6PD) catalyzes the rate-limiting step of the pentose phosphate pathway, generating NADPH that cells depend on for reductive biosynthesis and for maintaining glutathione in its reduced form to defend against oxidative stress. A G6PD assay typically uses a coupled colorimetric chemistry in which G6PD oxidizes glucose-6-phosphate to 6-phosphogluconate while reducing NADP+ to NADPH. The generated NADPH then reduces a WST-8 tetrazolium salt to an orange formazan product through an electron-coupling reagent (commonly 1-methoxy PMS), with absorbance read at approximately 450 nm proportional to G6PD activity.

Protocol highlights and purchasing considerations

Protocol Highlights

Kits are validated for serum, plasma, tissue homogenates, and cell lysates, with reported sensitivity down to about 0.01 U/L, reflecting the high analytical sensitivity achievable with this NADPH-coupled tetrazolium chemistry. Because G6PD activity in red blood cells specifically is the primary clinical and research interest in deficiency studies, researchers working with whole blood or erythrocyte lysates should confirm that a kit's validated sample types explicitly include this matrix rather than only serum or plasma, which reflects extracellular rather than intraerythrocytic enzyme activity. As with other NADPH-coupled assays, endogenous NADPH or interfering reducing substances in the sample can contribute background signal, so an appropriate blank control is an important part of the protocol.

Assay Kit Purchasing Considerations

Since the NADP+/NADPH-WST-8 coupled colorimetric chemistry used to measure G6PD activity is standard across suppliers, the practical points of comparison are validated sample matrix (particularly whether red blood cell lysates are explicitly supported, given the clinical relevance of erythrocyte G6PD activity) and reported sensitivity relative to the activity range expected in deficient versus normal samples. Because G6PD deficiency assessment often requires distinguishing clearly between deficient, intermediate, and normal activity levels (particularly relevant in heterozygous females due to X-linked mosaic expression), a kit's precision and reproducibility at the lower end of its detection range deserve particular scrutiny. For broader pentose phosphate pathway or oxidative stress research, confirming that a kit's protocol accounts for potential interference from other NADPH-generating enzymes present in the same lysate is a worthwhile consideration. As with any activity assay, it's good practice to review the full protocol before deciding on a kit, since the manual often reveals practical details, such as incubation times, control requirements, and data analysis steps, that aren't captured in the product summary alone.